Gilead cures 9,000 Hep C patients, collects $5.7 billion
Treatment of mice with doses of 30 μmol/kg/day S.C for 3 days protected mice from paracetamol-, bromobenzene-, CCl4-, furosemide- and thioacetamide-induced hepatotoxicity. The protective activity seemed to be due to inhibition of various types of CY P450 subtypes such as CYP 1A, CYP 2A ...
Sh ver bad a drawin, bu Biikes hepiures and always wat mor.Then whe h s i olde Bis mothe giveshim some pencls and a drawingboo,ad ebegins drawing ctureto. Bu they ae nevergood. When Bli five years old, hi mother gives himasmall blackboard and some piece ofchalk(粉笔). Heike tho...
Hepatitis C is not a rare disease. In the U.S. alone, as many as 4.7 million people live with Hep C. It’s a viral infection that spreads through the blood and causes liver damage. It had always been hard to treat until a drug company called Gilead developed Solvaldi. The medication...
This Week in HIV Research: Reducing the Cost of Hepatitis C Cures, and Atazanavir During Pregnancy Linked to Developmental DelaysBy Warren TongBarbara Jungwirth
Since writing a blog, Jefferys receives 150 emails a day from people in the US, Britain and elsewhere asking for help. "India's production of these generic Hep. C drugs is saving thousands of lives a week." 'Delhi buyers club'